Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 148

Snowflake hits public markets in $3.36bn IPO

Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.

Sep 16, 2020

Opendoor welcomes reverse merger

Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.

Sep 16, 2020

Cordovan dives out of QUB’s TruCorp

Cordovan Capital Partners has sold its stake in QUB-founded clinician training equipment supplier TruCorp at a 10.4-fold return.

Sep 15, 2020

Outset Medical outpaces expectations in $242m IPO

Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.

Sep 15, 2020

Oncorus goes on to IPO stage

Astellas and Celgene-backed immuno-oncology therapy developer Oncorus has filed to raise up to $86.3m following more than $150m in funding.

Sep 15, 2020

Monedo succumbs to pandemic-linked challenges

The PayU and Rakuten-backed digital lending platform has filed for bankruptcy after regulatory changes in two markets meant customers halted loan repayments.

Sep 15, 2020

C4 Therapeutics sees its way to IPO filing

Small molecule drug developer C4 has fied for a $100m initial public offering, three months after the Dana-Farber Cancer Institute spinout raised a $170m round.

Sep 14, 2020

Esri sets up nFrames for acquisition

University of Stuttgart has scored an exit with the acquisition of nFrames, a 3D mapping technology spinout also backed by Vector Informatik.

Sep 14, 2020

Singlife clings on to Aviva Singapore

The Sumitomo and Aflac-backed digital insurance and savings product provider has merged with Aviva Singapore to form a business valued above $2.3bn.

Sep 14, 2020

C4 Therapeutics sees its way to IPO filing

Kraft Group, Roche and Novartis are in line for exits after small molecule drug developer C4 filed for a $100m offering,

Sep 14, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here